Skip to main content
BrainCited

Alpha-GPC ： Age-Related Cognitive Decline

C

Research suggests Alpha-GPC may support cognitive function in elderly populations with age-related decline. It is used as a prescription drug in Europe for cognitive impairment, with studies showing improvements in cognitive function scores.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dalpha\u002Dgpc\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
結論

            
            
Research suggests Alpha-GPC may support cognitive function in elderly populations with age-related decline. It is used as a prescription drug in Europe for cognitive impairment, with studies showing improvements in cognitive function scores.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                
            

            
                Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized …
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: Cognitive decline
                
                
                効果: None
                
                
                None
                
            

            
            
対象集団: Alzheimer's disease patients

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
8

        
研究数

    

    

        
600

        
参加者数

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
グレード

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
                        
                        
                            
                                RCT
                            
                            
                            
                        
                    

                    

                        Medicine
                        2024
                        
                        3 件の引用
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
一般的な使用量

                

                    
                    

                        
general:

                        
300-600 mg/day

                    

                    
                    

                        
cognitivesupport:

                        
600-1,200 mg/day

                    

                    
                

                
                

                    上限量： Not established; well-tolerated up to 1,200 mg/day
                

                
            

            

            
            

                
研究で検討された用量

                

                    

                        
                            

                                用量
                                期間
                                効果
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                推奨摂取タイミング： Morning or split dose; with or without food
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
報告されている副作用

                    
    
                        
                        
  • 
                            ⚠
                            Headache
                        
    • 
                        
                        
  • 
                            ⚠
                            Insomnia
                        
    • 
                        
                        
  • 
                            ⚠
                            Dizziness
                        
    • 
                        
                        
  • 
                            ⚠
                            Gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Fishy body odor at high doses (TMAO conversion)
                        
    • 
                        
                    

                

                

                
                

                    
既知の相互作用

                    
    
                        
                        
  • 
                            ●
                            Anticholinergic medications (opposes Alpha-GPC effects)
                        
    • 
                        
                        
  • 
                            ●
                            Cholinesterase inhibitors (additive cholinergic effects)
                        
    • 
                        
                        
  • 
                            ●
                            Scopolamine (opposes cholinergic effects)
                        
    • 
                        
                    

                

                

                
                

                    

                        耐容上限摂取量： Not established; well-tolerated up to 1,200 mg/day
                    

                

                
            

            

                サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Alpha-GPC help with Age-Related Cognitive Decline?
            
        
        

            Based on 8 studies with 600 participants, there is limited but promising evidence that Alpha-GPC may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Alpha-GPC should I take for Age-Related Cognitive Decline?
            
        
        

            Studies have used various dosages. A commonly studied range is 300-600 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Alpha-GPC?
            
        
        

            Reported side effects may include Headache, Insomnia, Dizziness, Gastrointestinal discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Alpha-GPC and Age-Related Cognitive Decline?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
Alpha-GPC 他の症状・状態について

                    

                        
                        
                            Neurotransmitter Imbalance
                            B

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。